CoolSculpting, a popular FDA-cleared fat-freezing procedure, has gained significant attention in recent years as a seemingly noninvasive alternative to traditional liposuction. However, the dark side of this widely promoted treatment has come to light through the painful experience of renowned Canadian model Linda Evangelista. The 58-year-old fashion icon, once at the forefront of the industry, underwent CoolSculpting sessions from August 2015 to February 2016, only to find herself facing a nightmarish aftermath that led her to file a lawsuit against Zeltiq Aesthetics Inc. The dangers associated with CoolSculpting have raised concerns about its safety and effectiveness.

Linda Evangelista's Ordeal:

Linda Evangelista's candid revelations about her CoolSculpting experience have shed light on the potential dangers of this fat-freezing procedure. The model, who had previously blamed herself for the disfiguring consequences of the treatment, now speaks openly about the physical and emotional toll it took on her life. The shocking revelation of being left "permanently deformed" and diagnosed with paradoxical adipose hyperplasia (PAH) has sent shockwaves through the industry.

The Lawsuit and Settlement:

In her pursuit of justice, Evangelista filed a $50 million lawsuit against Zeltiq Aesthetics Inc., alleging that the rare complication of PAH rendered her unable to work. The lawsuit, settled in July 2022 for an undisclosed amount, marked a significant chapter in the discussion surrounding the safety of CoolSculpting. Evangelista's struggle serves as a cautionary tale for those considering the procedure as a quick fix for body contouring.

The Unfortunate Side Effects:

CoolSculpting has been marketed as a well-researched and safe procedure, with over 11 million treatments performed worldwide. However, Evangelista's case highlights that even FDA-cleared treatments are not without risks. The rare side effect of paradoxical adipose hyperplasia, characterized by the development of bulges on the body, poses a serious threat to the credibility of CoolSculpting as a reliable cosmetic option.

Industry Response and Controversies:

In response to Evangelista's case, a representative for CoolSculpting emphasized the extensive research supporting the procedure, with over 100 scientific publications and millions of successful treatments. However, controversies surrounding the safety of cosmetic procedures, especially when it comes to long-term consequences, continue to raise questions about the thoroughness of pre-market testing and the transparency of potential risks.

Linda Evangelista's harrowing experience with CoolSculpting serves as a stark reminder that even FDA-cleared procedures can have unforeseen and devastating consequences. While cosmetic treatments promise transformative results, the potential risks should not be underestimated. As the industry grapples with Evangelista's revelations, it is imperative for individuals considering such procedures to thoroughly research and weigh the potential risks against the promised benefits. The CoolSculpting case underscores the importance of informed decision-making in the realm of cosmetic enhancements, urging both consumers and the industry to prioritize safety and transparency.

By Alexander Brosda, CEO Sokörpe Laboratories